178 patents
Page 6 of 9
Utility
Scalable three-dimensional elastic construct manufacturing
23 Nov 20
Tissue repair and restoration can be performed using an elastic material formed from tropoelastin.
Anthony Steven Weiss, Suzanne Marie Mithieux
Filed: 9 Dec 13
Utility
Cenicriviroc for the Treatment of Fibrosis
18 Nov 20
The disclosure includes the use of cenicriviroc or a salt or solvate thereof and pharmaceutical compositions containing the same in the treatment of inflammation and connective tissue diseases and disorders, such as fibrosis, peritonitis, and liver injury.
Eric Lefebvre
Filed: 2 Jun 20
Utility
79h7osg2kqpfzf6jwwghvxyuy7ytf9xel77s5yij
18 Nov 20
Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache.
Andrew M. Blumenfeld, Mitchell F. Brin
Filed: 2 Aug 20
Utility
20cf9v y6ukrrvkminxtam180y4lurm
11 Nov 20
A breast implant includes a flexible shell having an anterior face including an outer surface and an inner surface, and a marker attached to the inner surface of the anterior face of the shell.
David J. SCHUESSLER, Alberto FLORES-PUJOL, Daniela RODRIGUEZ-ESTRADA
Filed: 7 May 20
Utility
h05 6nrts1h9mgwfcq00eyx1mwzj8mdi0wtgtwpo
11 Nov 20
Compositions useful as dermal fillers and methods using such compositions to treat various skin and soft tissue conditions.
Elizabeta PAVLOVIC, Monica A. SERBAN, Xiaojie YU, Nicholas J. MANESIS
Filed: 23 Jul 20
Utility
57x3ku6nv6ypkzjuebg82tkpf1t181y5cmfakez0i3altnz17o7ufq
4 Nov 20
The disclosure relates to methods of treating and/or preventing scarring that would otherwise result from an incision to an area of skin.
Robert DANIELS, Damien BATES, John St. Clair ROBERTS
Filed: 1 May 20
Utility
b2lp46wqp1ikj os1melv0qg75pvdvego64k80gaa
4 Nov 20
Biocompatible microparticles include an ophthalmically active cyclic lipid component and a biodegradable polymer that is effective, when placed into the subconjunctival space, in facilitating release of the cyclic lipid component into the anterior and posterior segments of an eye for an extended period of time.
James Chang, Patrick Hughes, Chin-Ming Chang
Filed: 5 Dec 19
Utility
c8lmlclp4aowg2gthwlmk4xq6r64q
4 Nov 20
Tissue repair and restoration can be performed using an elastic material formed from tropoelastin.
Anthony Steven WEISS, Suzanne Marie MITHIEUX
Filed: 22 Jul 20
Utility
1cz3pgxqven25evuerfe2bh50yjndxax8vt04zehe7g8m817 7y0ipc
2 Nov 20
Devices and methods for inserting an implant into skin or other tissue of a patient can include a hyaluronic thread that is coupled at along distal portion with an insertion device.
Antoine Duc, Bastien Mandaroux
Filed: 23 Jan 17
Utility
zolchtoitjsu0etfnyqzcukutdtt62vxxdtb5na389ejwy50qo16eotz6b
28 Oct 20
A method of manufacturing a tissue expander for implanting into a body of a living subject can include mixing granules of a solute with an elastomer.
David J. SCHUESSLER, Steven A. SCHULTZ
Filed: 12 Jul 20
Utility
z67z9adigkmka12erjh4s
21 Oct 20
Described herein are compounds for and methods of treating conditions or diseases in a subject by administering to the subject a pharmaceutical composition containing an effective amount of an α-adrenergic modulator.
Daniel W. Gil, John E. Donello, Wenkui K. Fang, Phong X. Nguyen, Ken Chow, Todd M. Heidelbaugh, Dario G. Gomez, Michael E. Garst, Santosh C. Sinha
Filed: 24 Nov 19
Utility
qyq9twkm ewqs1z4eqomfyfolyg4fw2hnbat22wva
21 Oct 20
A Clostridial toxin pharmaceutical composition comprising a Clostridial toxin, such as a botulinum toxin, wherein the Clostridial toxin present in the pharmaceutical composition is stabilized by a non-protein excipient such as a polyvinylpyrrolidone, a disaccharide, a trisaccharide, a polysaccharide, an alcohol, a metal, an amino acid, a surfactant and/or a polyethylene glycol.
Terrence J. Hunt
Filed: 30 Jun 20
Utility
brjeq6a 5hyu324qwigi2rz9b48nhktlo7bmb9lrdg3ryhcex174
21 Oct 20
The present invention is drawn to a low-cost “meso” device that is able to effectively deliver functional self-delivery siRNA to subject and inhibit expression of a gene in the subject as well as related methods.
Roger L. Kaspar, Tycho Speaker
Filed: 29 Jun 20
Utility
c8sr96p5erme4sx5jgcvmufle3d pmj92du8zxyblq1
19 Oct 20
A container-closure system includes a container configured to hold a therapeutic liquid and having a dispensing tip configured to dispense a dose of the therapeutic liquid.
Sai Shankar
Filed: 25 Jul 13
Utility
hzt7tq48pspdkkaujstixshck
12 Oct 20
The present invention relates to a method for treating dermal inflammation and dermal diseases by local or systemic delivery, in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2 (FPR2).
Veena Viswanath, Richard L. Beard, John E. Donello, Edward Hsia
Filed: 9 Sep 19
Utility
nshi06stpidjt2frk hcn
12 Oct 20
The present invention relates to imidazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor.
Richard L. Beard, Tien T. Duong, Michael E. Garst
Filed: 21 May 19
Utility
ej1n76wu8r8tpfakyfv75zb1xb8qmu501
7 Oct 20
A skin treatment can include applying a microneedle device to a region of the skin so that microneedles of the device penetrate the stratum corneum.
Justin J. Schwab, Michael Augarten, Zachary Dominguez, Ethan Franklin, Edwin J. Kayda, Jason Metzner
Filed: 29 Mar 20
Utility
ap7xzb7sntyocdjg3a1lnfwpoebmmfhw913 lbrstxfy0stzxvhqz46qoxq
7 Oct 20
Synthetic methods for preparing deoxycholic acid and intermediates thereof are provided.
Achampeta Rathan Prasad, Roy A. Swaringen, JR., John Gregory Reid, Robert M. Moriarty, Akhila Kumar Sahoo
Filed: 22 Apr 20
Utility
pbp1gk7iug59k68rdo1aq4gt o0
7 Oct 20
The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway.
Yanbin Liang, Chen Li, Iris Lee, Victor M. Guzman
Filed: 26 Mar 20
Utility
x48ykwvvlr4pe u850c9ax796mrgina773wazpxtgsenehm2n1
5 Oct 20
The present invention is directed to preservative-free solutions of brimonidine and timolol for lowering intra-ocular pressure and treatment of glaucoma.
Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly
Filed: 9 Jan 19